CPhI India 2018 (Delhi ) was held in Delhi on December 12-14, 2018. It is a new event in the South Asian market after CPhI Spain. Since its inception, the exhibition has attracted a lot of attention from the world's drug manufacturers and traders, especially from China.
As a leading manufacturer for cyclodextrin derivative in China, Binzhou Zhiyuan Biotechnology has been successful participating in CPHI India for three time.
Old customers are all satisfied with our injection grade / oral grade Hydroxypropyl betadex, Betadex sulfobutyl ether sodium, gamma cyclodextrin etc, and our service.Further discussion some technology, testing and price, etc. At the same time, many new exhibitors also visited Booth No. : 6.K21, which had a warm and friendly exchange on the production equipment, testing equipment, quality control, process indicators, delivery date and price.
Through the exhibition, we can continue to communicate with customers in technology, testing and applications, solve various problems of customers, and understand the development direction of customer development. It is an important way to guide our product development and lay a foundation for the future development of Binzhou Zhiyuan Biotechnology.
By participating in the exhibition, it not only expanded the company's popularity, but also broadened the way for the company to develop new customer resources, and enhanced the brand value and influence of Binzhou Zhiyuan Biotechnology!